Regulatory Considerations for Microbiome-based Therapeutics

Time: 9:00 am
day: Day Two

Details:

• Overview of investigational new drug protocol requirements
• CMC considerations for live biotherapeutic products
• CMC considerations for fecal transplant based products

Speakers: